116P Chondrosarcoma cells acquire multidrug resistance through mitochondrial transfer from adipose-derived stem cells
ESMO Rare Cancers · 2026-03 · 5 · 100322
DOI: 10.1016/j.esmorc.2026.100322 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2026-03. Verfasst von B. Bana. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chondrosarcoma (CS) remains highly refractory to chemotherapy, and the biological mechanisms underlying this intrinsic and acquired drug resistance are poorly understood. Mitochondrial transfer from stromal cells has recently emerged as a potential contributor to tumor metabolic reprogramming and therapy resistance. We investigated whether adipose-derived stem cells (ASCs) transfer mitochondria to CS cells and whether this interaction could underlie multidrug resistance.
Zitieren
APA
Bana, B. (2026). 116P Chondrosarcoma cells acquire multidrug resistance through mitochondrial transfer from adipose-derived stem cells. ESMO Rare Cancers, 5, 100322. https://doi.org/10.1016/j.esmorc.2026.100322
Vancouver
Bana B. 116P Chondrosarcoma cells acquire multidrug resistance through mitochondrial transfer from adipose-derived stem cells. ESMO Rare Cancers. 2026;5:100322. doi:10.1016/j.esmorc.2026.100322
BibTeX
@article{Bana2026,
author = {Bana, B.},
title = {116P Chondrosarcoma cells acquire multidrug resistance through mitochondrial transfer from adipose-derived stem cells},
journal = {ESMO Rare Cancers},
year = {2026},
volume = {5},
pages = {100322},
doi = {10.1016/j.esmorc.2026.100322}
}
EUVIMED